Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1

FEBS Letters

Volumn 587, Issue 1, 2013, Pages 17-22

  Kim, Juhyun ^a   Park, Ui Hyun ^b   Moon, Mino ^a   Um, Soo Jong ^b   Kim, Eun Joo ^a  

^a Dankook University   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Breast cancer; CAC1; ER ; LSD1; Transcriptional repression

Indexed keywords

CYCLIN DEPENDENT KINASE 2 ASSOCIATED CULLIN; ESTROGEN RECEPTOR ALPHA; HISTONE DEMETHYLASE; LYSINE SPECIFIC DEMETHYLASE 1; PACLITAXEL; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL DEATH; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG RESISTANCE; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CO-REPRESSOR PROTEINS; CULLIN PROTEINS; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HISTONE DEMETHYLASES; HISTONES; HUMANS; MUTANT PROTEINS; NEOPLASM PROTEINS; PACLITAXEL; PROMOTER REGIONS, GENETIC; PROTAMINE KINASE; RECOMBINANT PROTEINS; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEINS;

EID: 84871717481     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.10.054     Document Type: Article

References (20)

1. W. Shao, and M. Brown Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy Breast Cancer Res. 6 2004 39 52
2. C.K. Osborne, R. Schiff, S.A. Fuqua, and J. Shou Estrogen receptor: current understanding of its activation and modulation Clin. Cancer Res. 7 2001 4338s 4342s
3. G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc. Natl. Acad. Sci. USA 93 1996 5925 5930
4. K.M. Dobrzycka, S.M. Townson, S. Jiang, and S. Oesterreich Estrogen receptor corepressors a role in human breast cancer Endocr. Relat. Cancer 10 2003 517 536
5. L. Giacinti, P.P. Claudio, M. Lopez, and A. Giordano Epigenetic information and estrogen receptor alpha expression in breast cancer Oncologist 11 2006 1 8
6. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptor and coregulators Cell 108 2002 465 474
7. A.J. Horlein, A.M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C.K. Glass, and M.G. Rosenfeld Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor Nature 377 1995 397 404
8. J.D. Chen, and R.M. Evans A transcriptional co-repressor that interacts with nuclear hormone receptors Nature 377 1995 454 457
9. C.L. Smith, Z. Nawaz, and B.W. O'Malley Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen Mol. Endocrinol. 11 1997 657 666
10. R.M. Lavinsky, K. Jepsen, T. Heinzel, J. Torchia, T.M. Mullen, R. Schiff, A.L. Del-Rio, M. Ricote, S. Ngo, J. Gemsch, S.G. Hilsenbeck, C.K. Osborne, C.K. Glass, M.G. Rosenfeld, and D.W. Rose Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes Proc. Natl. Acad. Sci. USA 95 1998 2920 2925
11. E.J. Kim, J.S. Park, and S.J. Um Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo J. Biol. Chem. 277 2002 32020 32028
12. Y.S. Cho, E.J. Kim, U.H. Park, H.S. Sin, and S.J. Um Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor J. Biol. Chem. 281 2006 17588 17598
13. H.K. Lee, U.H. Park, E.J. Kim, and S.J. Um MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation EMBO J. 26 2007 3545 3557
14. B. Jung-Hynes, M. Nihal, W. Zhong, and N. Ahmad Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? J. Biol. Chem. 284 2009 3823 3832
15. Y. Kong, K. Nan, and Y. Yin Identification and characterization of CAC1 as a novel CDK2-associated cullin Cell Cycle 8 2009 3544 3553
16. X. Hu, and M.A. Lazar The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors Nature 402 1999 93 96
17. D.M. Heery, E. Kalkhoven, S. Hoare, and M.G. Parker A signature motif in transcriptional co-activators mediates binding to nuclear receptors Nature 387 1997 733 736
18. I. Garcia-Bassets, Y.S. Kwon, F. Telese, G.G. Prefontaine, K.R. Hutt, C.S. Cheng, B.G. Ju, K.A. Ohgi, J. Wang, L. Escoubet-Lozach, D.W. Rose, C.K. Glass, X.D. Fu, and M.G. Rosenfeld Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors Cell 128 2007 505 518
19. M.E. Lippman, J.C. Allegra, E.B. Thompson, R. Simon, A. Barlock, L. Green, K.K. Huff, H.M. Do, S.C. Aitken, and R. Warren The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer N. Engl. J. Med. 298 1978 1223 1228
20. M. Sui, Y. Huang, B.H. Park, N.E. Davidson, and W. Fan Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death Cancer Res. 67 2007 5337 5344